Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.9091 | 75 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.91185 | 74 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.90761 | 75 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.61861 | 71 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.89437 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.95129 | 76 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.01232 | 76 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.86674 | 74 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.9366 | 75 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.85556 | 74 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.0849 | 76 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.81252 | 74 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.91024 | 75 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.9017 | 75 |